The Energy Code

In this Deep Dive, Dr. Mike breaks down a randomized crossover trial comparing photobiomodulation, pneumatic compression boots, shockwave therapy, and passive rest in CrossFit athletes.

The findings reveal a striking disconnect between feeling recovered and actually being physiologically recovered. Compression boots and shockwave therapy earned high satisfaction scores, but failed to outperform passive rest for muscle damage or power recovery. Photobiomodulation combined with a static magnetic field was the only intervention to preserve vertical-jump performance, reduce biochemical markers of muscle damage, and strengthen endogenous antioxidant defenses over the following 24 to 48 hours.

The episode explores the study’s specific light protocol, the “invisible recovery window” immediately after intense exercise, and why mitochondrial and oxidative-stress recovery may matter more than how your legs feel in the moment.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

A randomised crossover trial comparing photobiomodulation therapy with other recovery strategies in CrossFit athletes

-

Key Quotes From Dr. Mike:

“The most striking finding was the massive disconnect between an athlete’s subjective feelings and their objective physiology.”

“Shock waves and compression boots might make post-WOD soreness more bearable, but they simply don’t help you regain peak power any faster.”

“Photobiomodulation combined with a static magnetic field was the only intervention that significantly outperformed passive rest.”

“To understand why photobiomodulation won, you have to look at the microscopic war zone inside your muscle cells... High-intensity CrossFit workouts trigger a massive spike in reactive oxygen species... Photobiomodulation acts as an internal antioxidant booster.”

“Pneumatic boots are mostly for show... The boots provided no statistically significant benefit over passive recovery for muscle damage or power output.”

“If you want to return to the barbell with maximum power, photobiomodulation is currently the only technology in this trial with scientific receipts to back it up.”

-

Key Points

⚡ The study compared photobiomodulation with a static magnetic field, pneumatic compression boots, shockwave therapy, and passive recovery in CrossFit athletes.

⚡ Compression boots and shockwave therapy received 83% satisfaction ratings, showing that athletes enjoyed the treatments.

⚡ Despite those high satisfaction scores, neither treatment significantly improved vertical-jump recovery or muscle-damage markers compared with passive rest.

⚡ The study highlights a major disconnect between subjective recovery and objective physiological recovery.

⚡ Photobiomodulation combined with a static magnetic field was the only intervention to significantly outperform passive recovery across functional and biochemical outcomes.

⚡ Athletes receiving PBM retained more vertical-jump power at the 24- and 48-hour marks.

⚡ PBM also reduced lactate dehydrogenase, a biomarker associated with muscle-cell membrane damage.

⚡ The study used a 32-minute protocol across eight treatment sites on each lower limb, targeting the quadriceps, hamstrings, and calves.

⚡ The device combined 905-nanometer super-pulsed lasers with 850-nanometer and 633-nanometer LEDs.

⚡ None of the recovery methods restored jump performance at the one-hour mark, including PBM.

⚡ PBM nevertheless increased antioxidant activity within 60 minutes, suggesting internal repair had begun before athletes felt or performed better.

⚡ PBM lowered markers of lipid and protein oxidation, including TBARS and carbonylated proteins.

⚡ It was also the only intervention to maintain or increase superoxide dismutase and catalase activity.

⚡ Compression boots may provide a strong sensory experience, but this trial did not show meaningful metabolic or performance recovery.

⚡ The central lesson: choose recovery tools based on how they affect performance 24 to 48 hours later—not merely how they feel immediately after training.

-

Episode timeline

00:00–01:49 — Introduction to the CrossFit recovery trial and the “science of the slay”

01:51–02:55 — Why a CrossFit WOD creates extreme mechanical, metabolic, and oxidative stress

02:57–04:30 — The satisfaction paradox: why compression boots and shockwave therapy feel effective without improving objective recovery

04:32–06:27 — PBM emerges as the leading intervention; improvements in jump performance and muscle-damage biomarkers

05:30–06:27 — The winning protocol: 32 minutes, eight sites per leg, and a combination of red/NIR LEDs and super-pulsed lasers

06:29–07:50 — The invisible recovery window: why no device restored performance one hour after the WOD

07:52–09:42 — The oxidative-stress battle: PBM’s effects on TBARS, carbonylated proteins, superoxide dismutase, and catalase

09:43–10:34 — Why pneumatic compression boots failed to outperform passive rest

10:35–11:24 — Feeling recovered versus being physiologically recovered

11:25–13:09 — The authors’ conclusion and the practical question every athlete should ask about recovery technology

13:11–13:27 — Closing message and podcast outro

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

In this Deep Dive, Dr. Mike Belkowski returns to the roots of The Energy Code by examining two newly published reviews on red light therapy. The first explores photobiomodulation for ocular aging and eye diseases, including age-related macular degeneration, dry eye, and childhood myopia. The second evaluates whether PBM can improve sleep quality by influencing brain metabolism, cerebral blood flow, neural networks, and melatonin-related pathways.

Dr. Mike breaks down how light interacts with mitochondrial cytochrome c oxidase, improves electron flow and ATP production, and may restore bioenergetics in two of the body’s most energy-demanding tissues: the brain and retina. The episode also examines the LIGHTSITE clinical trials, repeated low-level red-light therapy for myopia, transcranial PBM for sleep, extra-pineal melatonin production, and why proper wavelength, irradiance, and dosage remain essential.

The emerging message is that red light may be far more than a tool for skin, pain, and muscle recovery. It may represent an investigational strategy for restoring cellular energy in the tissues responsible for how clearly we see and how deeply we sleep.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Near-Infrared and Red-Light Photobiomodulation for Ocular Aging and Diseases: A Narrative Review

Photobiomodulation and sleep quality: systematic review and meta-analysis

-

Key Quotes From Dr. Mike:

“Many of the conditions we associate with aging and declining function may ultimately be manifestations of an underlying energy problem.”

“We are witnessing a bioenergetic tipping point where mitochondrial decay dictates the pace of systemic aging.”

“The human eye is an ideal target for PBM due to its optical accessibility and the immense energy demands of the retina.”

“Brief exposures to red light can slow the progression of myopia in children.”

“PBM may help restore homeostatic sleep pressure — the biological need to sleep... Red and near-infrared wavelengths have the capability of improving our systemic melatonin production.”

“The gastrointestinal tract is likely the largest source of melatonin in the body.”

“If mitochondria contribute to melatonin production, all of a sudden full-body red light therapy becomes imperative for normalizing circadian rhythm.”

-

Key Points

⚡ Two new reviews examine photobiomodulation for ocular aging and disease and for sleep quality.

⚡ The brain and retina are among the body’s most energy-demanding tissues, making them especially vulnerable to mitochondrial decline.

⚡ Red and near-infrared light interact with cytochrome c oxidase, helping displace inhibitory nitric oxide, restore oxygen utilization, and increase ATP production.

⚡ PBM follows a Goldilocks dose response: too little may do nothing, while excessive light can become inhibitory or pro-oxidative.

⚡ The LIGHTSITE clinical trials reported modest but statistically significant visual-acuity gains of roughly four to five ETDRS letters in patients with dry age-related macular degeneration.

⚡ Ocular PBM may also reduce drusen burden and potentially slow geographic atrophy, although further clinical confirmation is needed.

⚡ Repeated low-level red-light therapy is being studied as a way to slow the abnormal eyeball elongation responsible for childhood myopia.

⚡ Ocular protocols differ by goal: age-related macular degeneration often uses multiple red, amber, and near-infrared wavelengths, while myopia protocols typically use red light alone.

⚡ Wavelength determines penetration depth; device strength primarily determines how quickly a therapeutic dose is delivered.

⚡ High-powered panels should not be used close to the eyes without carefully adjusting distance, exposure time, and irradiance.

⚡ Transcranial PBM may support sleep by influencing adenosine signaling, cerebral metabolism, astrocytes, and prefrontal and thalamocortical networks.

⚡ Current sleep findings are statistically promising, but may not yet represent clinically meaningful improvements.

⚡ Red and near-infrared light may also support sleep indirectly by improving mitochondrial function and extra-pineal melatonin synthesis.

⚡ Melatonin is produced throughout the body — including the retina, gastrointestinal tract, skin, immune cells, cardiovascular tissues, and mitochondria — not only in the pineal gland.

⚡ PBM should currently be viewed as a promising adjunctive and investigational tool, not a replacement for established medical care.

-

Episode timeline

00:00–03:17 — Return to the podcast’s red-light roots; introduction to two new reviews on sleep and ocular PBM

03:18–05:54 — Why the retina and brain are ideal — and very different — targets for red and near-infrared light

05:55–06:44 — Research context and Francisco Gonzalez-Lima’s involvement in both papers

06:45–08:48 — The invisible cellular engine: mitochondrial decline, aging, and PBM as a nonthermal bioenergetic intervention

08:49–10:24 — The mitochondrial master switch: cytochrome c oxidase, nitric oxide displacement, oxygen utilization, ATP, and the biphasic dose response

10:25–13:28 — Saving sight: the LIGHTSITE clinical program, ETDRS letter gains, drusen reduction, and dry macular degeneration

13:29–16:25 — The myopia paradox: how low-level red light may slow abnormal eye elongation in children

16:27–17:56 — Comparing ocular protocols: multi-wavelength PBM for macular degeneration versus red-only treatment for myopia

17:58–21:20 — Practical eye-treatment considerations: irradiance, distance, exposure time, low-powered devices, and screen-light balancing

21:21–22:46 — The prefrontal “off switch”: transcranial PBM, adenosine signaling, brain-network efficiency, and sleep quality

22:47–23:21 — Research limitations: statistical significance versus clinically meaningful improvement

23:22–26:49 — Extra-pineal melatonin: the retina, gut, skin, immune cells, reproductive tissues, and mitochondria

26:50–27:38 — How consistent PBM, sunlight, evening darkness, and circadian lighting may work together to support sleep

27:40–29:35 — Final synthesis: PBM as an investigational adjunct, future applications in spaceflight, and illuminated healthcare

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

In Part 3 of his presentation at Dave Asprey's BEYOND Biohacking conference in May, Dr. Mike completes this three-part series by moving fully into the practical applications of mitochondrial optimization. After recapping the six pillars of mitochondrial function — energy production, mitogenesis, mitophagy, dynamics, ROS protection, and light — this episode breaks down the major tools, compounds, and lifestyle strategies that can help support each pillar.

Dr. Mike covers urolithin A and B, shilajit, mitochondrial peptides, nano gold, taurine, molecular hydrogen, deuterium depletion, hyperbaric oxygen therapy, circadian light, indoor lighting, and grounding. The episode then brings everything together into a practical “Energy Code Blueprint,” outlining a daily and weekly framework for the true mitochondriac: sunlight, grounding, mitohormesis, red light therapy, methylene blue, selective antioxidants, mitochondrial peptides, and foundational compounds that support cellular energy, resilience, and longevity.

(Educational content only, not medical advice.)

-

Key Quotes From Dr. Mike:

“Urolithin A is simply one of the most effective, efficient, efficacious ways to activate the mitophagy switch.”

“SS-31 arguably is the top peptide I would recommend for overall mitochondrial function.”

“MOTS-c… is essentially exercise in a molecule... Humanin… is known as a cognitive or neuroprotector in terms of a peptide... SHLP-2… is the cellular survival signal peptide... (SS-31, MOTS-c, Humanin & SHLP-2) are the peptides I would look at from a mitochondriac perspective.”

“Nano gold itself doesn’t create energy; it multiplies & amplifies the light that does.”

“Molecular hydrogen penetrates every cellular compartment, including the mitochondria.”

“Deuterium depletion is one of the most powerful overlooked levers to upgrade mitochondrial function.”

“Morning sun is a must.”

-

Key Points

⚡ This episode completes the three-part breakdown of The Energy Code Blueprint: Longevity Starts in the Mitochondria.

⚡ Part 3 focuses on the practical applications: what people can actually do to support the six pillars of mitochondrial function.

⚡ Urolithin A is framed as one of the most effective ways to activate mitophagy, helping clear damaged mitochondria and restore mitochondrial quality control.

⚡ Urolithin B is positioned as an anabolic mitokine that may support muscle retention, protein synthesis, joint health, and metabolic resilience.

⚡ Shilajit is described as a foundational mitochondrial compound because of its fulvic acid, trace minerals, CoQ10 support, and ability to improve ATP and EZ water production.

⚡ The four core mitochondrial peptides highlighted are SS-31, MOTS-c, SHLP-2, and Humanin, with honorable mentions for Epitalon, GHK-Cu, and Pinealon.

⚡ Nano gold is presented as a light-amplifying mitochondrial tool that may enhance the effects of red and near-infrared light via surface plasmon resonance.

⚡ Taurine is described as a mitochondrial game changer due to its effects on oxidative stress, ETC efficiency, mitophagy, inflammation, brain health, heart health, and calcium regulation.

⚡ Molecular hydrogen is framed as a selective antioxidant that neutralizes the most harmful radicals while preserving beneficial redox signaling.

⚡ Deuterium depletion is explained as an overlooked lever for improving ATP synthase efficiency, electron flow, mitochondrial respiration, and cellular energy.

⚡ Hyperbaric oxygen therapy is discussed as a mitochondrial oxygenation strategy that may improve ATP production, mitogenesis, cellular repair, and the nitric oxide “golden ratio.”

⚡ Circadian light hygiene—morning sun, evening darkness, amber/red lighting, and blue-light blocking—is positioned as a foundational mitochondrial signal.

⚡ Grounding is described as a free electron-transfer strategy that supports redox potential, inflammation control, blood flow, sleep, and mitochondrial function.

⚡ The final Energy Code Blueprint begins with the free foundations: sunlight, circadian rhythm, grounding, and mitohormesis.

⚡ The “multiplier effect” is the main theme: when foundational signals align, every other mitochondrial tool works better.

-

Episode timeline

0:00–2:10 — Part 3 intro and recap of Parts 1–2: bioenergetics, six pillars, and earlier applications

-

Introducing BioLight Labs!

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

In this peptide-focused Deep Dive, Dr. Mike explores Humanin, one of the most fascinating and underappreciated mitochondrial-derived peptides in the longevity space. First discovered in 2001 while researchers were searching for molecules that could protect neurons from Alzheimer’s-related toxicity, Humanin appears to act as one of the body’s natural cellular survival signals — helping cells withstand oxidative stress, inflammation, mitochondrial damage, metabolic dysfunction, and age-related decline.

This episode breaks down a 2023 systematic review from Biology titled “Humanin and Its Pathophysiological Roles in Aging”, covering Humanin’s unusual mitochondrial origin, its role in neuroprotection, mitohormesis, chaperone-mediated autophagy, metabolic health, cardiovascular function, inflammation, and lifespan research. Dr. Mike also explains why Humanin may deserve a place alongside SS-31 and MOTS-c as one of the top mitochondrial peptides for anyone interested in mitochondrial wellness, resilience, and longevity.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Humanin and Its Pathophysiological Roles in Aging: A Systematic Review

-

Key Quotes From Dr. Mike:

“Humanin was originally isolated from surviving neurons in the brains of patients with Alzheimer’s disease"

"It was named 'Humanin' to reflect its potential role in preserving human health and survival."

 “Humanin appears to function as one of the body’s natural cellular survival signals... acting as a molecular shield and mitokine."

“Humanin restores the communication link that tells the cleanup crew exactly where the toxic debris is hiding.”

“By addressing the mitochondrial origin of this inflammation — the leaky battery problem — Humanin hits multiple diseases simultaneously.”

"These are the top three peptides if you’re a mitochondriac: SS-31, MOTS-c, and now you can see why the third is Humanin.”

-

Key Points

⚡ Humanin is a small mitochondrial-derived peptide first discovered in 2001 during research into Alzheimer’s disease-related neuronal protection.

⚡ It was originally isolated from surviving neurons in the brains of Alzheimer’s patients, which helped shape its identity as a cellular survival peptide.

⚡ Humanin is encoded within the mitochondrial genome, specifically inside the 16S ribosomal RNA gene, giving mitochondria their own “voice” beyond ATP production.

⚡ It exists in two forms: a 21-amino-acid version when translated in mitochondria and a 24-amino-acid version when translated in the cytoplasm.

⚡ Humanin is highly conserved across species, suggesting it may play a fundamental role in multicellular survival and stress resistance.

⚡ It may protect against Alzheimer’s-related toxicity by interfering with amyloid beta toxicity and blocking pro-apoptotic pathways like Bax activation.

⚡ Humanin functions as a mitokine, released during periods of mitochondrial stress to coordinate resilience across cells and tissues.

⚡ Humanin levels generally decline with age, although some very old individuals may show compensatory spikes as a last-ditch mitohormetic stress response.

⚡ It supports chaperone-mediated autophagy, helping the cell’s “precision cleanup crew” remove damaged or oxidized proteins.

⚡ Humanin has broad systemic effects, including potential benefits for brain health, cardiovascular aging, insulin sensitivity, visceral fat, lean mass, inflammation, stem cell survival, and reproductive health.

⚡ Animal models suggest even modest increases in circulating Humanin may provide protection against toxic insults and inflammatory markers.

⚡ A synthetic analog called HNG / Humanin S14G may be up to 1,000 times more potent than naturally occurring Humanin in certain models.

⚡ Dr. Mike frames Humanin as the third part of a mitochondrial peptide “big three” alongside SS-31 and MOTS-c.

-

Episode timeline

0:00–0:40 — Introduction to Humanin as another mitochondrial-derived peptide; article title and source

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

In this episode of The Energy Code, Dr. Mike Belkowski breaks down BPC-157, one of the most popular and debated peptides in the wellness, recovery, and biohacking worlds. He covers its origins as a synthetic fragment of a protective compound found in gastric juice, its potential roles in tendon, ligament, muscle, gut, nerve, and tissue repair, and the major caveat around angiogenesis. The episode then unpacks a recent Pharmaceutics review highlighting the central paradox of BPC-157: decades of compelling animal data and powerful anecdotal reports, but still a major lack of rigorous human clinical evidence, standardized formulations, and long-term safety data. Ultimately, BPC-157 is framed as a high-potential, low-certainty peptide — promising enough to deserve serious attention, but not yet proven enough to justify blind faith.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers

-

Key Quotes From Dr. Mike:

“BPC-157 has been investigated primarily through studies looking at gastrointestinal protection, tissue repair, and healing mechanisms.”

“BPC-157’s gastric stability does not equal oral bioavailability… “The claim that oral BPC-157 reaches systemic circulation is an unverified hypothesis, not a clinical fact.”

“It enters the blood, triggers a response, and is cleared by the kidneys almost instantly. Yet its healing effects can persist for days or weeks.”

“There are over 544 peer-reviewed studies, mostly in rodents… In terms of total human efficacy subjects, there’s fewer than 30 people documented in all history.”

“For now, BPC-157 remains the ultimate biological paradox: a compound that can seemingly heal anything in the lab, but officially nothing in the clinic.”

-

Key Points

⚡ BPC-157 stands for Body Protecting Compound 157 and is derived from a protective protein found in human gastric juice.

⚡ It has been studied mostly in animal models for tissue repair, tendon healing, ligament recovery, muscle injury, gut protection, angiogenesis, nerve support, inflammation modulation, and oxidative stress reduction.

⚡ Despite its popularity, BPC-157 has almost no robust human clinical data.

⚡ A recent Pharmaceutics review describes BPC-157 as an investigational peptide with major formulation, pharmacokinetic, regulatory, and translational barriers.

⚡ BPC-157 is unusually stable in acidic stomach-like environments, but gastric stability does not prove oral bioavailability.

⚡ Its systemic half-life appears to be under 30 minutes, yet animal studies suggest effects may last days or weeks, creating a major pharmacokinetic/pharmacodynamic mystery.

⚡ The review suggests BPC-157 may act as a transcriptional primer, briefly triggering gene and growth-factor cascades that continue after the peptide is cleared.

⚡ The evidence base is heavily skewed toward preclinical animal studies, with very limited human data.

⚡ Much of the BPC-157 literature comes from one research group at the University of Zagreb, creating a need for independent replication.

⚡ BPC-157’s native stability may make it difficult to patent, reducing pharmaceutical incentive to fund large clinical trials.

⚡ Current gray-market products are research chemicals, not FDA-approved pharmaceutical-grade human therapeutics.

⚡ Potential risks include inconsistent dosing, lack of GMP oversight, lack of long-term safety data, and theoretical concern around angiogenesis in the setting of hidden malignancy.

⚡ Dr. Mike’s view: BPC-157 has earned scientific curiosity, but not scientific certainty.

-

Episode timeline

0:00 – Introduction to BPC-157

0:49 – The Review Being Covered

1:20 – Brief History of BPC-157

2:05 – Anecdotal Use and Recovery Claims

2:45 – Potential Benefits

3:36 – Angiogenesis Caveat

4:11 – The Phantom Peptide

5:42 – The Gastric Survivor

7:25 – The 30-Minute Phantom

8:49 – The 554-to-1 Evidence Gap

9:35 – The Zagreb Paradox

10:15 – Armor Made of Proline

10:47 – Why Big Pharma May Not Be Interested

11:48 – Regulatory Limbo

13:23 – What BPC-157 Needs Next

15:18 – Dr. Mike’s Viewpoint

16:55 – Scientific Curiosity vs. Scientific Certainty

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

In Part 2 of Dr. Mike's podcast special of his presentation from Dave Asprey's BEYOND Biohacking Conference, we finish all six pillars of mitochondrial wellness — from mitophagy (quality control) & mitochondrial dynamics (fusion/fission balance) to ROS intelligence (selective antioxidant strategy) & light (red/NIR as the master signal).

Then we move from theory to action: the episode begins the “applications” section with a practical, research-backed toolkit — red light therapy, methylene blue, blue spirulina, & Carbon 60 — including how they work, how they stack, & why the right strategy is less about “more antioxidants” & more about restoring electron flow, managing oxidative stress, & building cellular resilience.

(Educational content only, not medical advice.)

-

Key Quotes From Dr. Mike:

“If mitophagy is not working properly, then those damaged mitochondria are allowed to linger and be pro-inflammatory and be pro-oxidative stress.”

“Specifically, red and near-infrared are the spectra that excites the mitochondria and the cytochrome c oxidase. No other wavelengths accomplish this.”

“Simply by exposing your body… to red and near-infrared light (whether sun or red light therapy devices)… this is likely the most powerful way to remedy mitochondrial dysfunction.”

“Methylene blue is one of the only ways I know of that’s able to actually restore energy in mitochondria with broken electron transport chains.”

“We have an amazing natural alternative to methylene blue… and that is blue spirulina, which has phycocyanins that absorbs red light to protect neurons and strengthen our mitochondrial performance.”

“Carbon 60 is essentially a free radical sponge… it’s only gonna remove the excess ‘bad’ free radicals and allow the good signaling molecules to stay.”

-

Key Points

⚡️ Mitophagy = mitochondrial quality control: PINK1 “inspects,” Parkin “tags,” autophagosomes “remove.” When it fails, damaged mitochondria linger & inflammation/oxidative stress snowball.

⚡️ Dysfunctional mitochondria can self-propagate, accelerating decline unless quality control is restored.

⚡️ Mitochondrial dynamics (fusion/fission) is a Goldilocks game:

⚡️ ROS aren’t “all bad”: low-level ROS are essential signals; the goal is selective antioxidant defense, not blanket quenching.

⚡️ Light is a mitochondrial master regulator: red/NIR stimulate cytochrome c oxidase, dissociate nitric oxide, allow oxygen back in → better ATP + EZ water.

⚡️ Red light therapy is wavelength-driven, not “power-driven”: red = skin; NIR = deeper tissues; power mainly affects time-to-dose.

⚡️ Methylene blue = electron chaperone: bypasses ETC bottlenecks (esp. complex I/III) by shuttling electrons toward complex IV; synergizes with red light.

⚡️ Blue spirulina (phycocyanin) = natural photodynamic partner: less potent than MB but strong synergy with red light; quality matters (E10→E40).

⚡️ Carbon 60 = selective free radical sponge: mops up “excess” ROS while preserving beneficial signaling; quality control is crucial.

-

Episode timeline

-

Introducing BioLight Labs!

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

In this peptide-focused Deep Dive, Dr. Mike moves from SS-31 to MOTS-c — one of the most popular mitochondrial-derived peptides for metabolic resilience and mitochondrial wellness. You’ll get a fast, practical primer (what it is + key benefits), then a walkthrough of a review titled “MOTS-c Functionality Prevents Metabolic Disorders,” explaining how MOTS-c acts as a mitochondrial “telegram” to your DNA via retrograde signaling. The episode breaks down MOTS-c’s “exercise mimetic” mechanisms (AMPK activation via AICAR), its reported effects across metabolism, muscle, bone, immune aging, and senescence clearance, and finishes with an actionable playbook for supporting endogenous MOTS-c through mitohormetic lifestyle inputs — and a thoughtful strategy for stacking MOTS-c with SS-31.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

MOTS-c Functionally Prevents Metabolic Disorders

-

Key Quotes From Dr. Mike:

“MOTS-c… helps regulate cellular energy production, metabolic flexibility, and stress adaptation.”

“MOTS-c functionally prevents metabolic disorders.”

“When the cells are under metabolic stress, MOTS-c… can be rapidly transferred from mitochondria to the nucleus and regulates nuclear gene expression.”

“Because MOTS-c is easily destroyed by digestive enzymes, oral delivery remains a significant challenge…”

“Some researchers view MOTS-c as a mitochondrial distress signal… mitochondria release more MOTS-c when challenged, not when everything is perfectly comfortable.”

“If you want the best of both worlds (for mitochondrial optimization)... stack SS-31 and MOTS-c together.”

-

Key Points

-

Episode timeline

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

This is the first dedicated peptide deep dive of The Energy Code — and it starts with arguably the most mitochondrial-centric peptide on the board: SS-31 (Elamipretide). Dr. Mike breaks down a new paper showing how SS-31 may protect neurons in Parkinson’s disease by competing with alpha-synuclein at lipid membranes, slowing toxic aggregation, restoring mitochondrial respiration, and even reducing alpha-synuclein cellular entry. You’ll also hear a key caution: SS-31 appears highly protective at moderate doses, but too much may flip the benefit into harm, reinforcing the “dose makes the medicine” rule in mitochondrial pharmacology.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Therapeutic Peptide SS-31 Modulates Membrane Binding and Aggregation of α-Synuclein and Restores Impaired Mitochondrial Function

-

Key Quotes From Dr. Mike:

“The future of Parkinson’s therapy may not lie in cleaning up the mess, but rather in providing our neurons with a permanent molecular shield…”

“SS-31 acts as a molecular shield protecting the brain’s energy supply…”

“SS-31 acts as a molecular bouncer, physically evicting alpha-synuclein from lipid membranes…”

“SS-31 substantially prolonged the lag phase of aggregation, essentially stalling the clock on protein buildup.”

“These findings underscore the multifaceted protective role of SS-31 against mitochondrial dysfunction caused by alpha synuclein aggregation... SS-31 reversed this decline with a 10 micromolar dose…”

-

Key Points

-

Episode timeline

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

In this special edition of The Energy Code, Dr. Mike shares a more in-depth discussion on his presentation from Dave Asprey’s BEYOND Biohacking event in Austin: The Energy Code Blueprint: Longevity Starts in the Mitochondria. He introduces BioLight Labs’ initial focus on mitochondrial and longevity peptides, then delivers a thorough foundation on bioenergetics — why “more energy per cell” translates to more vitality, how redox/voltage and electrons relate to inflammation, and why mitochondria act as environmental sensors that drive epigenetics. From there, the episode begins the 6 Pillars of Mitochondrial Wellness, covering Pillar 1 (Energy Production ) —including electron transport chain efficiency and EZ water — and Pillar 2 (Mitogenesis) —with key activators like exercise, fasting, cold exposure, PQQ, urolithin A, and red/near-infrared light.

(Educational content only, not medical advice.)

-

Key Quotes From Dr. Mike:

“The more energy you produce per cell, the more vitality you will have... The less energy you produce per cell, the closer to a state of disease you will be.”

“Around 80% of modern diseases are directly tied to mitochondrial dysfunction.”

“Any wellness strategy that involves harnessing electrons is inherently anti-aging.”

“Epigenetics is rooted in the mitochondria. They sense your environment and then send signals to the cell nucelus, which then turns genes on/off based on those mitochondrial signals."

“Cardiolipin… is like the bedrock of mitochondrial function... Many researchers now believe cardiolipin deterioration is one of the central hallmarks of mitochondrial aging.”

“SS-31’s mission is to fix and repair and prevent damage to cardiolipin. This makes SS-31 the MOST IMPORTANT peptide for mitochondrial function and anti-aging, from the bioenergetic perspective."

“After the age of 30, we typically lose about 1% of energy production annually.”

“Mitochondrial decline drives the hallmarks of aging... The future is clearly bioenergetic.”

-

Key Points

-

Episode timeline

-

Introducing BioLight Labs!

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook

This Deep Dive breaks down a preprint review from Free Radical Biology & Medicine titled “Mitoredox Shifts in Mitochondrial Dysfunction.” Dr. Mike opens with a TL;DR and then goes deeper into the core idea: a “mitoredox shift” (a disruption in mitochondrial redox balance) may be the unifying axis linking oxidative stress to mitochondrial quality-control failure, genome instability, heteroplasmy drift, and regulated cell death. The episode draws a clean line between primary genetic mitochondrial syndromes and far more common secondary mitochondrial dysfunction driven by environmental/metabolic stressors, then explores five big concepts: why redox imbalance collapses mitophagy and mtDNA stability, how “healthy” mitochondria can become hyperactive and accelerate disease, the 60–80% heteroplasmy tipping point, the reperfusion paradox, and emerging frontiers like mitochondrial transplantation, AI-driven oculomics, and new redox-modulating drugs — plus Dr. Mike’s “mitochondrial triad” lens (red light, methylene blue, C60).

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Mitoredox shifts in mitochondrial dysfunction

-

Key Quotes From Dr. Mike:

“Mito-redox shifts… serve as a central link between oxidative stress and various diseases.”

“These shifts destabilize essential cellular processes such as mitophagy and mitochondrial DNA stability…”

“We are entering an era of mito redox medicine where we manage the electron flow of life itself.”

“The retina is the only part of the central nervous system that can be imaged non-invasively… Whereby fluorescence imaging can detect metabolic failures years before physical symptoms appear… that is game changing.”

“Life is defined by the steady controlled flow of electrons… when that flow is disrupted… our mitoredox shifts towards mitochondrial dysfunction and, ultimately, disease."

-

Key Points

-

Episode timeline

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight Labs: 

Website

Instagram

BioLight:

Website

Instagram

YouTube

Facebook